A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Clinical trial NCT04511845 · COMPLETED
Trial details
- NCT number
- NCT04511845
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2026-06-18
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.